Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1195 of 6351
-
New hope for migraine sufferers: rimegepant shows promise in prevention trial
Disease control CompletedThis study is being conducted to evaluate the efficacy and tolerability of rimegepant for migraine prophylaxis in adults with a history of inadequate response to oral preventive medications
Phase 4 • Sponsor: Pfizer • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
New mRNA flu shot shows promise in early trial
Vaccine CompletedThe main purpose of the study is to evaluate the safety, reactogenicity, and the humoral immunogenicity of mRNA-1010 and comparator influenza vaccines against homologous influenza A and B strains at Day 29.
Phase 2 • Sponsor: ModernaTX, Inc. • Aim: Vaccine
Last updated Jun 27, 2026 07:59 UTC
-
Herbal granules take on a stomach condition that raises cancer risk
Disease control CompletedChronic atrophic gastritis (CAG) is a common and frequently-occurring disease, characterized by atrophy of gastric mucosal epithelium and glands, thinning of the mucosa, thickening of the submucosal muscle layer, intestinal metaplasia, and atypical hyperplasia. The course of the …
Phase 2 • Sponsor: Chinese University of Hong Kong • Aim: Disease control
Last updated Jul 29, 2026 00:00 UTC
-
Could a laser ease painful sex for millions of women?
Symptom relief CompletedThis is a multicenter randomized controlled trial (RCT) investigating the effects of laser treatments in women suffering from provoked vestibulodynia compared to a sham-laser treatment. Following their enrollment in the study, participants will undergo a gynecological examination…
Sponsor: Université de Sherbrooke • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC
-
Overnight DNA test could speed up cancer care for kids
Knowledge-focused Recruiting nowCambridge University Hospitals NHS Foundation Trust (CUHNFT) is the Principal Treatment Centre for the East of England region, responsible for 120-150 patients \<16 years with a new diagnosis of paediatric malignancy annually; leukaemia comprises \~25% of these cases. Current mol…
Sponsor: University of Cambridge • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:03 UTC
-
One-Day fix for spinal tumors? new trial combines surgery and radiation
Symptom relief Recruiting nowThe BLEND RCT aims to evaluate the (cost-)effectiveness of same-day SBRT and surgical stabilization with or without decompression for the treatment of symptomatic, unstable spinal metastases on physical functioning four weeks after the start of treatment, compared with the standa…
Sponsor: UMC Utrecht • Aim: Symptom relief
Last updated Jun 27, 2026 12:30 UTC
-
Tailored heart procedure aims to beat atrial fibrillation
Disease control Recruiting nowAtrial fibrillation (AF) is the most common arrhythmia with an expected rise in prevalence over the next decade. Catheter ablation is a safe treatment option in eliminating AF however, success rates still remains variable. Existing strategies do not take into account the differen…
Sponsor: Barts & The London NHS Trust • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC
-
Hope for pompe patients: could a switch in enzyme therapy slow decline?
Disease control OngoingThe goal of this clinical trial is to study the efficacy and safety of treatment with avalglucosidase alfa in patients with late onset Pompe disease that previously deteriorated on alglucosidase alfa. The main question it aims to answer is: * Is switching to avalglucosidase alf…
Phase 4 • Sponsor: Iris Plug • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Could a simple nutritional plan boost survival after liver procedure?
Disease control Recruiting nowThe hypothesis is that in patients with cirrhosis and refractory ascites candidate to TIPS, and sarcopenia (identified by a PMA ≤16 cm² at the level of L3), who are at high-risk of 6-month mortality after TIPS placement, a post-TIPS 12 weeks nutritional intervention is associated…
Phase 3 • Sponsor: The Mediterranean Institute for Transplantation and Advanced Specialized Therapies • Aim: Disease control
Last updated Jul 16, 2026 00:00 UTC
-
Could two years of hormone therapy be enough for some breast cancers?
Disease control Recruiting nowHormone therapy is recommended for five years in all patients with hormone receptor-positive breast cancer, but there is no consensus on its duration in low-risk tumours and especially in postmenopausal women. Adjuvant endocrine therapy (ET) is associated with substantial side ef…
Phase 2 • Sponsor: UNICANCER • Aim: Disease control
Last updated Jul 23, 2026 00:00 UTC
-
Peanut allergy pill shows promise in early trial
Disease control CompletedA study to evaluate the safety, efficacy and tolerability of remibrutinib at three doses versus placebo in adult participants who have a confirmed allergy to peanuts. The efficacy was measured by the ability of participants to tolerate increasing doses of peanut protein during an…
Phase 2 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 13:08 UTC
-
Can an ancient herbal formula tame gout?
Disease control CompletedGout is a chronic disease of deposition of monosodium urate crystals, which form in the presence of increased urate concentrations. Gout is closely related to hyperuricaemia. Urate deposits in the joint, causing joint swelling, pain, movement disorders, affecting a significant po…
Phase 2 • Sponsor: Chinese University of Hong Kong • Aim: Disease control
Last updated Jul 29, 2026 00:00 UTC
-
Could early Blood-Pressure drugs be a Game-Changer for sepsis?
Disease control Recruiting nowSepsis is a life-threatening reaction to an infection. It happens when the immune system overreacts to an infection and starts to damage the body's tissues and organs. The aim of this research study is to compare the two different ways to treat sepsis, in the early phase of trea…
Phase 3 • Sponsor: NHS Greater Glasgow and Clyde • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
Weight loss pill shows promise in major trial
Disease control CompletedThis study will look how well semaglutide tablets taken once daily helps people with body weight above the healthy range. Participants will either get semaglutide 25 milligram (mg) once daily or placebo once daily. This study will last for 72 weeks, which includes 1-week screenin…
Phase 3 • Sponsor: Novo Nordisk A/S • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC
-
Biobank aims to unlock genetic secrets of rare diseases
Knowledge-focused Recruiting nowNext generation sequencing (NGS) allows some better diagnostic results, particularly, in the rare diseases field. At a twenty five percent rate, those exams highlight some variants which are not yet described in human pathology. The relationship between a variant found inside a c…
Sponsor: University Hospital, Angers • Aim: Knowledge-focused
Last updated Jul 01, 2026 00:00 UTC
-
Could blocking a Tumor's blood supply shrink brain meningiomas?
Disease control Recruiting nowThe natural course for meningioma suggests that a majority will grow over time. Treatment is usually indicated in growing or symptomatic meningiomas. Surgery is usually primary treatment, but there is a significant risk of adverse effects. Stereotactic radiotherapy is most often …
Sponsor: St. Olavs Hospital • Aim: Disease control
Last updated Jul 23, 2026 00:00 UTC
-
Could a standard 28-Day antibiotic course beat flexible dosing for abdominal infections?
Disease control OngoingA multicentre, open label, two-arm, parallel group, pragmatic, randomised controlled trial with internal pilot. A total of 1166 consenting adult patients with cIAI will be recruited and randomised on a 1:1 basis between 28-days antibiotics and standard care antibiotics. Patients …
Phase 3 • Sponsor: Lydia Flett • Aim: Disease control
Last updated Jul 26, 2026 00:00 UTC
-
Eye stroke treatment put to the test: can clot busters save sight?
Disease control Stopped earlyNon-arteritic, thromboembolic central retinal artery occlusion (CRAO) is an acute neurovascular-ophthalmological emergency which leads to severe and permanent vision loss; no evidence-based therapy does exist. Two recent meta-analyses indicate early intravenous thrombolysis to be…
Phase 3 • Sponsor: University Hospital Tuebingen • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
New drug BIIB115 aims to build on gene therapy for spinal muscular atrophy
Disease control OngoingIn this study, researchers will learn about a study drug called BIIB115 in healthy adult male volunteers and in participants with spinal muscular atrophy (SMA). This study will focus on children with SMA. The main objective of the study is to learn about the safety of BIIB115 an…
Phase 1 • Sponsor: Biogen • Aim: Disease control
Last updated Jul 11, 2026 00:00 UTC
-
Smartwatch could spot silent heart rhythm problem after surgery
Diagnosis Recruiting nowThe incidence of postoperative atrial fibrillation (POAF) after on-pump cardiac surgery remains high, at around 30%. POAF increases the risk of cardiac decompensation, stroke, acute myocardial infarction, and death, resulting in increased morbidity and mortality, hospital length …
Sponsor: Centre Hospitalier Universitaire, Amiens • Aim: Diagnosis
Last updated Jun 27, 2026 09:08 UTC